Non-cognitive neuropsychiatric symptoms (NPS) of dementia include
aggression, agitation, depression, anxiety, delusions, hallucinations, apathy,
and disinhibition. These affect dementia patients nearly universally across
dementia stages and etiologies. NPS are associated with poor patient and
caregiver outcomes including excess morbidity and mortality, increased health
care utilization, and earlier nursing home placement, as well as caregiver
stress, depression and reduced employment. While there is no FDA-approved
pharmacotherapy for NPS, psychotropic medications are frequently used to manage
these symptoms. However, in the few cases of proven pharmacologic efficacy,
benefit may be off set by significant risk of adverse effects. Non-pharmacologic
treatments, typically considered first-line, also show evidence for efficacy as
well as a limited potential for adverse effects. However, their uptake as
preferred treatments remains inadequate in real-world clinical settings. Thus,
the field currently finds itself between a “rock and a hard
place” in terms of management of these difficult symptoms. It was in
this context that the University of Michigan Program for Positive Aging, working
in collaboration with the Johns Hopkins Alzheimer’s Disease Research
Center and Center for Innovative Care in Aging sponsored and convened a
multidisciplinary expert panel in Detroit Michigan in Fall 2011 with three
objectives, to: 1) define key elements of care for NPS in dementia; 2) construct
an approach describing the sequential and iterative steps of managing NPS in
real-world clinical settings that can be used as a basis for integrating
non-pharmacologic and pharmacologic approaches; 3) discuss how the approach
generated could be implemented in research and clinical care.